搜索
市场行情
自选
新闻
分析
交易工具
选股器
扫码下载
一键诊股 让投资更聪明
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
登录
免费注册
搜索
免费注册
市场行情
/
股票
/
医药与医学研究
/
生物技术与医疗研究
/
lyel
/
财务摘要
Lyell Immunopharma Inc
LYEL
添加自选
10.120
USD
-0.410
-3.89%
收盘 09-24 16:00(美东)
236.10M
总市值
亏损
市盈率 TTM
Lyell Immunopharma Inc
10.120
-0.410
-3.89%
概览
新闻分析
财务
股票评分
技术分析
预测
持股情况
股息
公司资料
财务摘要
利润表
资产负债表
现金流量表
财报
公司估值
风险评估
概览
新闻分析
财务
股票评分
技术分析
预测
持股情况
股息
公司资料
财务摘要
利润表
资产负债表
现金流量表
财报
公司估值
风险评估
LYEL 财务数据
通过专为投资者打造的一站式数据看板,全面查看 Lyell Immunopharma Inc 的财务状况。平台将复杂的财务报表整理为可自定义的视图,助您更轻松地进行财务分析。您可以查看最新年度财务报告,也可以通过利润表、资产负债表和现金流量表,按季度分析公司表现。借助实时财务指标,持续追踪公司的经营状况和市场表现更加便捷。
关键财务比率
总市值
236.10M
股息TTM
0.00
市盈率 TTM
-0.74
每股收益TTM
-13.62
营业收入
36.00K
净利润
-342.99M
净资产收益率
-80.76%
总资产收益率
-63.15%
Lyell Immunopharma Inc 财报日历
最新发布
8月 6, 2026
每股收益 / 预测值
-1.92
/-2.02
营业收入 / 预测值
4.00K
/3.29K
财务报表摘要
单季报
单季报+年报
单季报
年报
YOY
隐藏空白行
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
财务指标
每股收益
33.61%
-1.92
68.79%
-1.10
49.98%
-6.86
38.87%
-2.13
19.56%
-2.89
25.87%
-3.54
-227.46%
-13.71
14.04%
-3.48
29.76%
-3.59
11.06%
-4.77
-546.80%
-4.19
--
-4.05
--
-5.11
--
-5.37
--
-0.65
--
-0.71
--
--
--
--
--
--
--
--
营业收入
-50.00%
4.00K
-71.43%
2.00K
-45.45%
6.00K
-55.88%
15.00K
-38.46%
8.00K
133.33%
7.00K
-15.38%
11.00K
36.00%
34.00K
-51.85%
13.00K
-95.38%
3.00K
-99.97%
13.00K
733.33%
25.00K
-99.92%
27.00K
-88.25%
65.00K
1614.60%
48.39M
-99.89%
3.00K
1260.01%
35.74M
-77.38%
553.00K
22.06%
2.82M
157.48%
2.75M
净利润
-4.85%
-44.76M
53.73%
-24.15M
26.68%
-140.72M
12.87%
-38.85M
6.82%
-42.68M
13.96%
-52.20M
-262.62%
-191.94M
12.33%
-44.58M
28.30%
-45.81M
9.40%
-60.67M
-530.34%
-52.93M
27.62%
-50.85M
-75.89%
-63.89M
1.74%
-66.96M
89.97%
-8.40M
-43.74%
-70.25M
41.97%
-36.32M
-23.80%
-68.14M
-115.42%
-83.71M
-36.83%
-48.88M
利润率
-109.70%
-1118875.00%
-61.96%
-1207650.00%
-34.42%
-2345383.33%
-97.50%
-258973.33%
-51.41%
-533550.00%
63.13%
-745642.86%
-328.55%
-1744863.64%
35.54%
-131126.47%
-48.91%
-352376.92%
-1863.07%
-2022233.33%
-2346041.46%
-407153.85%
--
-203412.00%
--
-236629.63%
--
-103013.85%
--
-17.35%
--
-481.36%
--
--
--
--
--
--
--
--
毛利率
0.00%
100.00%
0.00%
100.00%
0.00%
100.00%
0.00%
100.00%
0.00%
100.00%
0.00%
100.00%
0.00%
100.00%
0.00%
100.00%
0.00%
100.00%
0.00%
100.00%
0.00%
100.00%
--
100.00%
--
100.00%
--
100.00%
--
100.00%
--
100.00%
--
--
--
--
--
--
--
--
资产负债率
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.00%
--
0.00%
--
0.00%
--
0.00%
--
0.00%
--
0.00%
--
--
--
--
--
--
--
--
利润表
营业收入
-50.00%
4.00K
-71.43%
2.00K
-45.45%
6.00K
-55.88%
15.00K
-38.46%
8.00K
133.33%
7.00K
-15.38%
11.00K
36.00%
34.00K
-51.85%
13.00K
-95.38%
3.00K
-99.97%
13.00K
733.33%
25.00K
-99.92%
27.00K
-88.25%
65.00K
1614.60%
48.39M
-99.89%
3.00K
1260.01%
35.74M
-77.38%
553.00K
22.06%
2.82M
157.48%
2.75M
营业利润
-6.05%
-47.34M
23.01%
-44.26M
2.93%
-61.31M
28.00%
-37.25M
15.67%
-44.75M
-5.28%
-57.49M
-1.40%
-63.16M
12.36%
-51.74M
19.48%
-53.06M
15.03%
-54.61M
-181.96%
-62.29M
7.75%
-59.04M
-95.71%
-65.91M
11.27%
-64.26M
53.53%
-22.09M
-30.18%
-64.00M
46.30%
-33.67M
-30.81%
-72.43M
-20.28%
-47.54M
-33.43%
-49.16M
净利润
-4.85%
-44.76M
53.73%
-24.15M
26.68%
-140.72M
12.87%
-38.85M
6.82%
-42.68M
13.96%
-52.20M
-262.62%
-191.94M
12.33%
-44.58M
28.30%
-45.81M
9.40%
-60.67M
-530.34%
-52.93M
27.62%
-50.85M
-75.89%
-63.89M
1.74%
-66.96M
89.97%
-8.40M
-43.74%
-70.25M
41.97%
-36.32M
-23.80%
-68.14M
-115.42%
-83.71M
-36.83%
-48.88M
资产负债表
流动资产
-24.33%
213.54M
-13.54%
267.30M
-31.26%
260.94M
-27.07%
328.20M
-43.54%
282.21M
-42.12%
309.18M
-31.57%
379.59M
-23.31%
450.05M
-17.58%
499.82M
-14.45%
534.16M
-14.83%
554.69M
-11.05%
586.85M
-9.05%
606.41M
-0.21%
624.40M
3.99%
651.29M
4.53%
659.75M
-20.13%
666.78M
2.62%
625.71M
--
626.29M
--
631.15M
流动负债总额
8.03%
39.87M
-10.51%
36.95M
-8.14%
49.41M
-4.88%
31.88M
19.51%
36.90M
27.61%
41.28M
55.82%
53.79M
-4.43%
33.51M
-10.21%
30.88M
5.05%
32.35M
-6.78%
34.52M
-31.54%
35.06M
-31.62%
34.39M
-24.99%
30.80M
-20.78%
37.03M
-13.60%
51.22M
-21.00%
50.29M
-27.74%
41.05M
--
46.74M
--
59.28M
总资产
-19.28%
311.15M
-18.42%
350.63M
-30.72%
340.05M
-34.12%
407.96M
-41.08%
385.45M
-38.09%
429.80M
-34.55%
490.86M
-22.11%
619.22M
-21.69%
654.14M
-21.15%
694.22M
-20.00%
750.03M
-18.65%
794.99M
-18.24%
835.35M
-17.88%
880.45M
-16.84%
937.56M
-18.45%
977.27M
-16.93%
1.02B
22.22%
1.07B
--
1.13B
--
1.20B
总负债
-10.62%
77.34M
-17.49%
76.96M
-14.98%
91.85M
-10.93%
78.84M
-1.27%
86.53M
2.43%
93.28M
13.63%
108.03M
-9.13%
88.52M
-11.02%
87.64M
-5.76%
91.06M
-8.85%
95.08M
-38.05%
97.42M
-35.89%
98.50M
-49.37%
96.62M
-47.22%
104.31M
-25.78%
157.24M
-26.11%
153.63M
-4.70%
190.85M
--
197.62M
--
211.86M
总权益
-21.78%
233.81M
-18.68%
273.67M
-35.17%
248.20M
-37.98%
329.12M
-47.23%
298.92M
-44.21%
336.52M
-41.55%
382.82M
-23.92%
530.70M
-23.12%
566.50M
-23.05%
603.16M
-21.40%
654.95M
-14.93%
697.57M
-15.11%
736.86M
-11.06%
783.83M
-10.38%
833.25M
-16.87%
820.03M
-15.06%
868.04M
30.19%
881.25M
--
929.79M
--
986.47M
现金流量表
经营净额
1.56%
-33.92M
29.65%
-38.51M
31.73%
-32.25M
18.45%
-28.58M
9.54%
-34.46M
-30.28%
-54.74M
-16.26%
-47.24M
7.02%
-35.04M
2.72%
-38.09M
9.08%
-42.02M
-0.91%
-40.63M
-1.57%
-37.69M
11.67%
-39.16M
3.43%
-46.21M
-21.38%
-40.27M
-45.55%
-37.10M
-30.59%
-44.33M
-42.43%
-47.85M
-24.09%
-33.17M
-17.87%
-25.49M
投资净额
23.48%
15.62M
-74.98%
17.38M
-158.62%
-31.36M
74.61%
3.35M
-71.90%
12.65M
215.84%
69.47M
153.14%
53.51M
-98.08%
1.92M
-70.57%
45.01M
-31.60%
21.99M
-315.85%
-100.69M
274.60%
99.67M
511.18%
152.91M
223.09%
32.15M
163.12%
46.65M
60.61%
-57.09M
163.38%
25.02M
-119.11%
-26.12M
-328.18%
-73.90M
-61.11%
-144.91M
融资净额
185.25%
522.00K
5172100.00%
51.72M
-49.20%
222.00K
--
50.00M
-78.77%
183.00K
-96.30%
1.00K
-42.42%
437.00K
100.00%
0.00
-27.93%
862.00K
139.13%
27.00K
-12.05%
759.00K
-103.00%
-143.00K
-51.32%
1.20M
-102.70%
-69.00K
-88.34%
863.00K
996.42%
4.76M
-99.38%
2.46M
189.03%
2.56M
2089.05%
7.40M
-1617.14%
-531.00K
常见问题
Lyell Immunopharma Inc的总收入是多少?
根据Lyell Immunopharma Inc的FY2025财报,总收入达到了36.00K(同比变化61.00K)。
Lyell Immunopharma Inc的流动资产是多少?
根据Lyell Immunopharma Inc的FY2025财报,流动资产为260.94M(同比变化-31.26)。
Lyell Immunopharma Inc的总资产是多少?
根据Lyell Immunopharma Inc的FY2025财报,Lyell Immunopharma Inc的总资产为340.05M(同比变化-30.72)。
Lyell Immunopharma Inc的总负债是多少?
根据Lyell Immunopharma Inc的FY2025财报,Lyell Immunopharma Inc的总负债为91.85M(同比变化-14.98)。
Lyell Immunopharma Inc的总权益是多少?
根据Lyell Immunopharma Inc的FY2025财报,Lyell Immunopharma Inc的总权益为248.20M(同比变化-35.17)。
Lyell Immunopharma Inc的净营业收入是多少?
根据Lyell Immunopharma Inc的FY2025财报,Lyell Immunopharma Inc的净营业收入为-201.63M(同比变化8.95)。
Lyell Immunopharma Inc的净投资是多少?
根据Lyell Immunopharma Inc的FY2025财报,Lyell Immunopharma Inc的净投资为54.10M(同比变化-55.81)。
Lyell Immunopharma Inc的净融资是多少?
根据Lyell Immunopharma Inc的FY2025财报,Lyell Immunopharma Inc的净融资为50.41M(同比变化3701.36)。
Lyell Immunopharma Inc的每股收益(EPS)是多少?
根据Lyell Immunopharma Inc的FY2025财报,每股收益(EPS)为-16.06(同比变化38.80)。
Lyell Immunopharma Inc的净利润是多少?
根据Lyell Immunopharma Inc的FY2025财报,净利润为-274.45M(同比变化19.98)。
Lyell Immunopharma Inc的净利润率是多少?
根据Lyell Immunopharma Inc的FY2025财报,净利润率为-762355.56(同比变化-35.58)。
Lyell Immunopharma Inc的股东权益回报率(ROE)是多少?
根据Lyell Immunopharma Inc的FY2025财报,股东权益回报率(ROE)为-86.98(同比变化-31.59)。
Lyell Immunopharma Inc的资产回报率(ROA)是多少?
根据Lyell Immunopharma Inc的FY2025财报,资产回报率(ROA)为-66.06(同比变化-19.50)。
Lyell Immunopharma Inc的营业利润是多少?
根据Lyell Immunopharma Inc的FY2025财报,营业利润为-201.63M(同比变化8.95)。